Sunday, October 14, 2012

Dems in Coal States Diverge on Obama Policies

{ttle}

{cptn}","template_name":"ss_thmb_play_ttle","i18n":{"end_of_gallery_header":"End of Gallery","end_of_gallery_next":"View Again"},"metadata":{"pagination":"{firstVisible} - {lastVisible} of {numItems}","ult":{"spaceid":"7645365","sec":""}}},{"id": "hcm-carousel-1016348422", "dataManager": C.dmgr, "mediator": C.mdtr, "group_name":"hcm-carousel-1016348422", "track_item_selected":1,"tracking":{ "spaceid" : "7645365", "events" : { "click" : { "any" : { "yui-carousel-prev" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"prev","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } }, "yui-carousel-next" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"next","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // no more pages, don't beacon again // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } } } } } } })); }); Y.later(10, this, function() {(function() { try{ if (Math.floor(Math.random()*10) == 1) { var loc = window.location, decoded = decodeURI(loc.pathname), encoded = encodeURI(decoded), uri = loc.protocol + "//" + loc.host + encoded + ((loc.search.length > 0) ? loc.search + '&' : '?') + "_cacheable=1", xmlhttp; if (window.XMLHttpRequest) xmlhttp = new XMLHttpRequest(); else xmlhttp = new ActiveXObject("Microsoft.XMLHTTP"); xmlhttp.open("GET",uri,true); xmlhttp.send(); } }catch(e){} })(); }); Y.later(10, this, function() {Y.namespace("Media").ywaSettings = '"projectId": "10001256862979", "documentName": "", "documentGroup": "", "ywaColo" : "vscale3", "spaceId" : "7645365" ,"customFields" : { "12" : "classic", "13" : "story" }'; Y.Media.YWA.init(Y.namespace("Media").ywaSettings); }); Y.later(10, this, function() {if(document.onclick===YAHOO.Media.PreventDefaultHandler.newClick){document.onclick=YAHOO.Media.PreventDefaultHandler.oldClick;} }); }); });

Saturday, October 13, 2012

Mount Diablo Unified Community Advisory Committee on Special ...

By Nirvi Shah from On Special Education

When a federal judge this week threw out a copyright infringement lawsuit against universities working on a project with Google to digitize millions of books, he unleashed Google's plans and opened the door to the distribution of these books to people who are blind or have other print disabilities.

The National Federation of the Blind on Thursday applauded the ruling, saying it will give blind students and scholars fresh access to the 10 million books placed in the digital library created by Cornell University, Indiana University, University of California, University of Michigan, and the University of Wisconsin.

Read more HERE.

Source: http://mtdiablosped.blogspot.com/2012/10/google-ruling-on-digitizing-books-boon.html

alex o loughlin the godfather cape breton bowling green marysville tornados dr. seuss

Shot fired at Obama campaign office in Denver

{ttle}

{cptn}","template_name":"ss_thmb_play_ttle","i18n":{"end_of_gallery_header":"End of Gallery","end_of_gallery_next":"View Again"},"metadata":{"pagination":"{firstVisible} - {lastVisible} of {numItems}","ult":{"spaceid":"2145892301","sec":""}}},{"id": "hcm-carousel-1178388271", "dataManager": C.dmgr, "mediator": C.mdtr, "group_name":"hcm-carousel-1178388271", "track_item_selected":1,"tracking":{ "spaceid" : "2145892301", "events" : { "click" : { "any" : { "yui-carousel-prev" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"prev","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } }, "yui-carousel-next" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"next","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // no more pages, don't beacon again // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } } } } } } })); }); Y.later(10, this, function() {(function() { try{ if (Math.floor(Math.random()*10) == 1) { var loc = window.location, decoded = decodeURI(loc.pathname), encoded = encodeURI(decoded), uri = loc.protocol + "//" + loc.host + encoded + ((loc.search.length > 0) ? loc.search + '&' : '?') + "_cacheable=1", xmlhttp; if (window.XMLHttpRequest) xmlhttp = new XMLHttpRequest(); else xmlhttp = new ActiveXObject("Microsoft.XMLHTTP"); xmlhttp.open("GET",uri,true); xmlhttp.send(); } }catch(e){} })(); }); Y.later(10, this, function() {Y.namespace("Media").ywaSettings = '"projectId": "10001256862979", "documentName": "", "documentGroup": "", "ywaColo" : "vscale3", "spaceId" : "2145892301" ,"customFields" : { "12" : "classic", "13" : "story" }'; Y.Media.YWA.init(Y.namespace("Media").ywaSettings); }); Y.later(10, this, function() {if(document.onclick===YAHOO.Media.PreventDefaultHandler.newClick){document.onclick=YAHOO.Media.PreventDefaultHandler.oldClick;} }); }); });

Stop Bullying the Compounding Pharmacy | VitalityLogix

In the wake of the meningitis outbreak stemming from theNew EnglandCompoundingCenter?s methylprednisolone, the spotlight is suddenly on this small but important sector of the retail pharmacy market.

Compounding pharmacies specialize in making customized formulations of existing medications to fit special needs of their patients. This ranges from simple customization of a flavored antibiotic mixture for a child or as complex as chemotherapy for sterile infusion into the epidural space (spine). The NECC made a formulation from a common steroid used for spine injection for patients with back pain. This batch became contaminated with fungus and caused deadly meningitis in dozens of cases. Sounds bad, right?

Well, let?s put this into perspective. While this incident is undoubtedly a terrible and unfortunate event (and my sympathies go out to those affected by this event), it pales in comparison to the social and financial cost of Big Pharma?s practices and incidents. Let?s examine a few examples.

Sibutramine (now off the market) was developed as a treatment for obesity and was approved by the FDA, only to be pulled from the market after killing thousands of people from cardiovascular events. This drug underwent the requisite randomized controlled trials (which then became the focus of a Senate committee review) and after several years on the market it was withdrawn by the manufacturer under pressure from the FDA (the same agency that approved it a few years before).

Erythropoetin Stimulating Agents, now at the center of the hot-off-the-presses USADA and federal report of the Armstrong dropping scandal, was developed as a treatment for anemia. It was, and is extremely effective. It reduced fatigue, improved quality of life, improved exercise capacity (and illegally made its way into the bodies of countless athletes, of which Lance Armstrong has been made an example of). The manufacturer reaped the financial rewards of their discovery. Now the drug carries a black box warning (something the FDA puts on a drug to warn prescribers and consumers of its danger) for increased risks of death from cardiovascular events such as strokes, heart attacks and blood clots in a wide range of patients, including those simply undergoing surgery and taking this drug.

Estrogen and Progestin hormone replacement therapy became a popular treatment for menopause in the late 1990s and beyond, until the drug-sponsored Women?s Health Initiative trial, along with a few others, reported increased risks of breast cancer after tens of thousands of women were already prescribed the drug. This led to a black box warning, a very embarrassing and financially costly situation for the manufacturer and had far-reaching implications for menopause treatment henceforth. This drug study is now the focal point for opponents of HRT for women. This study and HRT became a hot topic for compounding pharmacies and Big Pharma.

The Women?s Health Initiative was the study of a single drug that, like most pharmaceutical agents is completely unlike our own innate physiology and therefore exerts adverse events when introduced into the human body. While bio-identical hormones have been around for many years, they are not amenable to patent since the structure is already part of human physiology and thus Big Pharma has little interest in bio-identical hormones as a commercial venture. Bio-identical hormones are largely made by compounding pharmacies into customized, patient specific creams. Big Pharma generally has nothing to gain from this, just like most of the other compounded products. Big Pharma is interested in patents, profits, and protection of their market share. And there is no reason to blame them for this as they are a business and a business needs to profit. However, their business deals with human lives.

In the wake of the negative Women?s Health Initiative and the growth of the compounded bio-identical hormone market (supported by encouraging trials from Europe), extensive lobbying efforts were exerted on the FDA and medical associations to come out against bio-identical hormones and compounding pharmacies as an unsafe alternative to the traditional Big Pharma methods. Claims were made that compounded bio-identicals are not safer than the Big Pharma products (and are often dangerous) and that there is no evidence to support their use. That is (and was) just not true. Large studies have been conducted inEuropeclearly supporting lower breast cancer risks and possibly even null risks in women using bio-identical compounded HRT. The lobbyists, politicians, and many medical groups jumped to support Big Pharma and bully the small compounding pharmacists with faulty claims and skewed evidence.

Yes, the compounding pharmacies need licensing, oversight, and regulation. But when you compare the damage inflicted by compounding pharmacies and Big Pharma, it?s like comparing the populations ofVatican CityandChina.

Compounding pharmacies serve a vital role in the retail pharmacy market and provide a fundamental service for many practitioners and patients alike. How do you treat a cancer patient with mouth sores from chemotherapy that are so bad that he cant even swallow water? A compounding pharmacist developed a pain-relieving and sore coating mouthwash. It can only be compounded. How do you infuse chemotherapy into the spine of a 3 year old child? A compounding pharmacist, under sterile conditions, has to make a formulation for that purpose. How do you give someone with a fear of needles an injectable medication? Compound it into a nasal spray. How do you effectively treat menopause while minimizing the breast cancer risks and providing an alternative to Big Pharma products? Compound bio-identical HRT.

The problem is that compounding offers patients and practitioners an alternative to Big Pharma and that?s bad for business. I?m not blaming Big Pharma ? they have accomplished amazing things and saved countless lives in generally safe ways. But they are an aggressive, highly lobbied and connected business that will attack any and all competition, often to the detriment of patients and practitioners alike.

So let?s put this NECC incident into perspective and treat it for what it is ? an unfortunate sentinel event (defined by the Joint Commission as an unexpected occurrence involving death or serious physical or psychological injury). According to the Joint Commission website ?Such events are called ?sentinel? because they signal the need for immediate investigation and response.? Rather than bully compounding pharmacies into extinction and financial ruin, this NECC incident should prompt politicians, regulators, and medical watch groups, and medical professional organizations to support compounding pharmacies in developing, instituting and enforcing guideline for safe practice. So let?s stop bullying and start working together to make sure this is a lesson that leads to change and improvement rather than a witch hunt.

?

Source: http://www.vitalitylogix.com/blog/stop-bullying-the-compounding-pharmacy/

fletcher cox charlotte bobcats new york rangers nfl mock draft 2012 norfolk island michael brockers lisa marie presley

Actress who starred in 'Bad News Bears' killed

LOS ANGELES (AP) ? Sammi Kane Kraft, whose baseball skills earned her the role of a youth league pitcher in the 2005 remake of "The Bad News Bears," has died in a Los Angeles car crash. She was 20.

The Los Angeles Times (http://lat.ms/RgLEIq ) says Kraft was a passenger in an Audi that rear-ended a big rig and was struck by another car at about 1:30 a.m. Tuesday on Interstate 10.

Her brother, Frankie Kane, tells the Times that Kane was pronounced dead at a hospital.

The California Highway Patrol says the Audi's driver was treated for moderate injuries and arrested on suspicion of drunken driving.

Kraft was 13 when she was discovered on an LA baseball diamond and cast in her only film. She played the role originated by Tatum O'Neal in 1976.

___

Information from: Los Angeles Times, http://www.latimes.com

Source: http://news.yahoo.com/actress-starred-bad-news-bears-killed-143331743--spt.html

westminster dog show 2012 words with friends words with friends phlebotomy dog show best in show bret michaels

Friday, October 12, 2012

Fusion energy: Mug handles could help hot plasma give lower-cost, controllable fusion energy

ScienceDaily (Oct. 11, 2012) ? Researchers around the world are working on an efficient, reliable way to contain the plasma used in fusion reactors, potentially bringing down the cost of this promising but technically elusive energy source. A new finding from the University of Washington could help contain and stabilize the plasma using as little as 1 percent of the energy required by current methods.

"All of a sudden the current energy goes from being almost too much to almost negligible," said lead author Thomas Jarboe, a UW professor of aeronautics and astronautics. He presents the findings this week at the International Atomic Energy Association's 24th annual Fusion Energy Conference in San Diego.

The new equipment looks like handles on a coffee mug -- except they attach to a vessel containing a million-degree plasma that is literally too hot to handle.

Most people know about nuclear fission, the commercial type of nuclear power generated from splitting large atoms in two. Still under research is nuclear fusion, which smashes two small atoms together, releasing energy without requiring rare elements or generating radioactive waste.

Of course, there's a catch -- smashing the atoms together takes a lot of energy, and scientists are still working on a way to do it so you get out more energy than you put in. The sun is a powerful fusion reactor but we can't recreate a full-scale sun on Earth.

An international project in France is building a multibillion-dollar fusion reactor to see whether a big enough reactor can generate fusion power.

The reactor in France will inject high-frequency electromagnetic waves and high-speed hydrogen ions to sustain the plasma by maintaining an even hotter 100-million-degree operating temperature and enclosing it with magnetic fields.

"That method works," Jarboe said, "but it's extremely inefficient and expensive, to the point that it really is a major problem with magnetic confinement."

For two decades Jarboe's team has worked on helicity injection as a more efficient alternative. Spirals in the plasma produce asymmetric currents that generate the right electric and magnetic fields to heat and confine the contents. Plasma is so hot that the electrons have separated from the nuclei. It cannot touch any walls and so instead is contained by a magnetic bottle. Keeping the plasma hot enough and sustaining those magnetic fields requires a lot of energy.

"We would drive it until it was unstable," Jarboe said of his approach. "Like you twist up a rope, the plasma twists up on itself and makes the instability and makes the current drive."

Results showed the UW strategy required less energy than other methods, but the system was unstable, meaning that if conditions change it could wobble out of control. It's like a stick balancing on one end, which is stable at that moment, but is likely to come crashing down with any nudge. In the case of plasma, unstable equilibrium means that a twist in the plasma could cause it to escape and potentially lead to a costly reactor shutdown.

Instability was a major impediment to applying the UW method.

"The big issue is whether, when you distort the bottle, it will leak," Jarboe said.

By contrast, in a stable equilibrium, any shift will tend to come back toward the original state, like a ball resting at the bottom of a bowl that will settle back where it started.

"Here we imposed the asymmetric field, so the plasma doesn't have to go unstable in order for us to drive the current. We've shown that we can sustain a stable equilibrium and we can control the plasma, which means the bottle will be able to hold more plasma," Jarboe said.

The UW apparatus uses two handle-shaped coils to alternately generate currents on either side of the central core, a method the authors call imposed dynamo current drive. Results show the plasma is stable and the method is energy-efficient, but the UW research reactor is too small to fully contain the plasma without some escaping as a gas. Next, the team hopes to attach the device to a larger reactor to see if it can maintain a sufficiently tight magnetic bottle.

The research is funded by the U.S. Department of Energy. Co-authors are Brian Nelson, research associate professor of electrical engineering; and research associate Brian Victor, research scientists David Ennis, Nathaniel Hicks, George Marklin and Roger Smith and graduate students Chris Hansen, Aaron Hossack, Cihan Ackay and Kyle Morgan, all in UW aeronautics and astronautics.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of Washington. The original article was written by Hannah Hickey.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/matter_energy/physics/~3/d7NOr289Fk0/121011151629.htm

manson bubba watson recent earthquakes fbi most wanted list stuttering james van der beek dyngus day

Worker's injury casts harsh new light on Foxconn and China

HONG KONG (Reuters) - Apple Inc's largest contract manufacturer has been pushing for a Chinese worker left brain-damaged in a factory accident to be removed from hospital in a case that throws a harsh new spotlight on labor rights in China.

Zhang Tingzhen, 26, an employee of Taiwan firm Foxconn, had nearly half his brain surgically removed after surviving an electric shock at a plant in southern China a year ago. He remains in hospital under close observation by doctors, unable to speak or walk properly.

However, Foxconn, which is paying Zhang's hospital bills, has been sending telephone text messages to his family since July, demanding they remove him from hospital and threatening to cut off funding for his treatment - a move the firm says would be justified under Chinese labor law.

Foxconn confirmed it had sent the messages, saying that under Chinese law the worker must submit himself to a disability assessment - a process that in Zhang's case would require him to be discharged from the Shenzhen hospital and travel 70 km (43 miles) to Huizhou, where he was first hired by Foxconn.

The firm said in response to emailed questions that it would be prepared to return Zhang to the Shenzhen hospital after the assessment, though his father said Zhang was unfit to travel and that doctors felt he remained at risk of a brain haemorrhage.

The case has raised fresh questions over the labor record of Foxconn, one of the biggest and most high-profile private employers in China, after a series of well-publicized suicides among its army of around a million workers and recent outbursts of labor unrest.

It has angered labor activists who say Zhang's plight also highlights China's patchy and sometimes precarious welfare system for workers seriously injured in industrial accidents - and point out that there are many workers worse off than Zhang.

"They kept sending me SMSs every day to get my son out of hospital and to appear before an injury assessment body or they will stop paying all expenses, including his medical fees and our living expenses," said Zhang's father, Zhang Guangde.

"You cannot imagine the suffering they put me through, how I had to fight every inch of the way just to get money so we can take care of our son," he added, speaking at his son's bedside at the Number 2 People's Hospital in Shenzhen.

Zhang was repairing a spotlight on an external wall at a Foxconn factory in Shenzhen, bordering Hong Kong, when he received an electric shock and fell four meters (12 feet) to the ground. He has since undergone five operations, has lost his memory, is incontinent and requires careful, regular monitoring.

'ROBBED OF DIGNITY'

Workers who are disabled in workplace accidents and covered by insurance are eligible for compensation payouts, once their disability is assessed and graded by a panel of medical experts. The assessment is done after medical treatment is finished.

Foxconn sent the text messages, and according to Zhang's father at one point briefly halted payments to the family, despite a provincial law stipulating that injured workers can remain in treatment for up to two years before they must be assessed for disability compensation.

Zhang, whose case was alerted to Reuters by labor activists, has been in hospital since October 2011.

Doctors at the Number 2 People's Hospital declined to comment for this article, but Zhang's father, 50, said they had not indicated that he could be discharged and had said they needed to keep his son under observation after implanting a tube in his body to drain fluid from his brain cavity to his bladder.

"The doctor told me they needed to monitor his condition and that for such serious injuries, a person was allowed to be treated in hospital for up to two years. After that, assessors can order treatment to be prolonged," the father said.

Labor activists in China say Zhang is just one of many thousands of Chinese workers who are left permanently disabled or chronically ill by workplace accidents, at the mercy of a system that often requires them and their families to fight degrading battles for treatment funding and compensation.

"China now has laws specifying the types of compensation that are due to workers. But in many serious industrial accidents, companies still put workers or their families through a lot of suffering just to get what is due to them," said Choi Suet-wah of the Chinese Working Women Network in Hong Kong.

"They are robbed of their dignity," said Choi, who has extensive experience working with migrant workers in China.

Zhang is actually one of the lucky ones, social workers say, pointing out that Foxconn has at least been paying his hospital bills and the living expenses of his family, which has moved to Shenzhen from central China to be with him.

They estimate that at least four out of 10 Chinese workers are not covered by any kind of insurance and are left to fend for themselves when seriously injured in the workplace - despite laws requiring all employers to insure their workers.

"This is just one of many, many industrial accidents in China. And you almost certainly never get what you are entitled to, especially in serious cases," Choi said.

WELFARE BORDERS

Foxconn says it is insured against workplace accidents, which means its insurer would meet the cost of a compensation payment once Zhang's disability is finally assessed.

But compensation in China can vary depending on the city in which a worker's disability is assessed - and this, according to Zhang's family, is why Foxconn wants him to travel to Huizhou and refuses to have him assessed in Shenzhen.

Labor activists say wages and compensation levels are all substantially lower in Huizhou than in Shenzhen, one of the most expensive cities in China.

When asked why Zhang could not be assessed in Shenzhen, Foxconn said the law required him to go to Huizhou because he had signed his employment contract there. It added that it was prepared to send him back to the hospital in Shenzhen if the assessors determined that he required more medical attention.

In hospital, Zhang walks unsteadily, holding on to the bed frames of other patients in his shared room and, with a smile, sits down next to his father whose face tightens with emotion.

"He calls me 'mother' and calls my wife 'father'. He can only mimic words you ask him to say, it is meaningless," the elder Zhang said later, holding a jar containing large fragments of his son's cranium. Doctors replaced a portion of Zhang's skull with synthetic bone.

He said that despite Foxconn's funding - a monthly allowance of 11,000 yuan ($1,800) plus treatment costs - the family had racked up 200,000 yuan ($31,800) in debt to pay for medicines not provided by the hospital and other expenses.

Back home in central Henan province, the family was building a house for Zhang's impending marriage when he was injured.

"We were building a three-storey house," the elder Zhang said. "The project has since been abandoned and all the building materials we bought have been washed away by rain. But these workers still have to be paid. My whole life is over."

($1 = 6.2878 yuan)

(Additional reporting by China bureau; Editing by Mark Bendeich and Nick Macfie)

Source: http://news.yahoo.com/workers-injury-casts-harsh-light-foxconn-china-210449872--finance.html

patsy cline pierre thomas beyonce gives birth portlandia kelly clarkson playoffs empty nest